176 related articles for article (PubMed ID: 33376408)
1. Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.
Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Karlstad Ø; Juzeniene A; Ghiasvand R; Larsen IK; Green AC; Veierød MB; Robsahm TE
Clin Epidemiol; 2020; 12():1389-1401. PubMed ID: 33376408
[TBL] [Abstract][Full Text] [Related]
2. Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.
Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Furu K; Juzeniene A; Roscher I; Larsen IK; Green AC; Veierød MB; Robsahm TE
Clin Epidemiol; 2020; 12():193-202. PubMed ID: 32110111
[TBL] [Abstract][Full Text] [Related]
3. Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study.
Ghiasvand R; Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Karlstad Ø; Juzeniene A; Larsen IK; Green AC; Veierød MB; Robsahm TE
Int J Epidemiol; 2023 Jun; 52(3):887-898. PubMed ID: 36413027
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.
Berge LAM; Andreassen BK; Stenehjem JS; Larsen IK; Furu K; Juzeniene A; Roscher I; Heir T; Green A; Veierød MB; Robsahm TE
BMJ Open; 2019 Feb; 9(2):e025246. PubMed ID: 30787091
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet radiation and risk of cutaneous melanoma and squamous cell carcinoma in males and females in the Norwegian Offshore Petroleum Workers cohort.
Liu FC; Grimsrud TK; Veierød MB; Robsahm TE; Ghiasvand R; Babigumira R; Shala NK; Stenehjem JS
Am J Ind Med; 2021 Jun; 64(6):496-510. PubMed ID: 33682179
[TBL] [Abstract][Full Text] [Related]
6. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.
Andreassen BK; Støer NC; Martinsen JI; Ursin G; Weiderpass E; Thoresen GH; Debernard KB; Karlstad Ø; Pottegard A; Friis S
BMJ Open; 2019 Apr; 9(4):e028504. PubMed ID: 30962244
[TBL] [Abstract][Full Text] [Related]
8. Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study.
Gordon D; Gillgren P; Eloranta S; Olsson H; Gordon M; Hansson J; Smedby KE
Melanoma Res; 2015 Aug; 25(4):348-56. PubMed ID: 26050147
[TBL] [Abstract][Full Text] [Related]
9. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
11. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjögren's syndrome: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Huang WC; Lu LY
Clin Exp Rheumatol; 2019; 37(6):946-952. PubMed ID: 31074727
[TBL] [Abstract][Full Text] [Related]
12. Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.
Siiskonen SJ; Koomen ER; Visser LE; Herings RM; Guchelaar HJ; Stricker BH; Nijsten TE
Eur J Clin Pharmacol; 2013 Jul; 69(7):1437-44. PubMed ID: 23471440
[TBL] [Abstract][Full Text] [Related]
13. Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
Loeb S; Folkvaljon Y; Lambe M; Robinson D; Garmo H; Ingvar C; Stattin P
JAMA; 2015 Jun 23-30; 313(24):2449-55. PubMed ID: 26103029
[TBL] [Abstract][Full Text] [Related]
14. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma.
Damento GM; Pulido JS; Abbott BA; Hodge DO; Dalvin LA
Mayo Clin Proc; 2019 Jul; 94(7):1287-1295. PubMed ID: 31272570
[TBL] [Abstract][Full Text] [Related]
15. Sun behaviour after cutaneous malignant melanoma: a study based on ultraviolet radiation measurements and sun diary data.
Idorn LW; Datta P; Heydenreich J; Philipsen PA; Wulf HC
Br J Dermatol; 2013 Feb; 168(2):367-73. PubMed ID: 23013402
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
Polesie S; Gillstedt M; Paoli J; Osmancevic A
Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
[TBL] [Abstract][Full Text] [Related]
17. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
Bangash HK; Colegio OR
Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
[TBL] [Abstract][Full Text] [Related]
18. A 3-year follow-up of sun behavior in patients with cutaneous malignant melanoma.
Idorn LW; Datta P; Heydenreich J; Philipsen PA; Wulf HC
JAMA Dermatol; 2014 Feb; 150(2):163-8. PubMed ID: 24080851
[TBL] [Abstract][Full Text] [Related]
19. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Lu LY; Lam HC; Tsai KW; Huang WC; Shiue YL
Clin Exp Rheumatol; 2018; 36(3):471-478. PubMed ID: 29303707
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cutaneous malignant melanoma in Iranian provinces and American states matched on ultraviolet radiation exposure: an ecologic study.
Moslehi R; Zeinomar N; Boscoe FP
Environ Pollut; 2018 Mar; 234():699-706. PubMed ID: 29241156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
